CV of an Avoro analyst.
Samir Devalaraja
MD/PhD | Analyst
Samir earned his MD and PhD in Immunology from the Perelman School of Medicine at the University of Pennsylvania, where he was the recipient of the Saul Winegrad Award for outstanding dissertation. His thesis uncovered a novel immune evasion mechanism in solid tumors and was published in Cell. Concurrent with graduate school, Samir consulted for venture-backed biotech companies in the gene therapy and precision oncology spaces. He holds a BA in History & Sociology of Science from the University of Pennsylvania. Samir joined Avoro Capital in 2021 and is focused on evaluating biotechnology investment opportunities.
Industry news, page-167
-
- There are more pages in this discussion • 1,953 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.000(0.00%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.66 | $1.65 | $51.86K | 31.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17732 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 1057 | 1 |
View Market Depth
| Last trade - 11.57am 29/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |